Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection

Sponsor
Jagiellonian University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04513210
Collaborator
(none)
300
1
22.6
13.3

Study Details

Study Description

Brief Summary

Ultrasound can reliably detect morphologic changes associated with pneumonia. Additionally, protocols were elaborated which unify the investigation procedure and improve the intra- and interrater reliability. Moreover, ultrasound is a time and cost-effective and widely available method. The aim of this study is to evaluate the efficacy of the ultrasound of the lungs in predicting the length of hospitalization, of intensive care and of mechanical ventilation in Covid-19 pneumonia. Further aims are the evaluation of the efficacy of the ultrasound of the lungs in predicting the risk of death and of long-term pulmonary complications as consequences of Covid-19 pneumonia.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Covid-19 pneumonia became the worldwide, serious health problem, affecting nearly 20 million people and causing nearly one million deaths. The health systems of many countries are overwhelmed with the increased need of medical care, of the number of available hospital beds, intensive care beds and ventilators. The proper management of available resources becomes now critical. Ultrasound can reliably detect morphologic changes associated with pneumonia, especially in Covid-19 pneumonia, where the involvement of superficial parts of the lungs predominates. Additionally, protocols were elaborated which unify the investigation procedure and improve the intra- and interrater reliability. Moreover, ultrasound is a time and cost-effective and widely available method. Finally, it is much easier to take measures, which minimize the risk of viral transmission between patients for ultrasound equipment than for other lung imaging devices such as x-ray or computer tomography. The aim of this study is to evaluate the efficacy of the ultrasound of the lungs in predicting the length of hospitalization, of intensive care and of mechanical ventilation in Covid-19 pneumonia. Further aims are the evaluation of the efficacy of the ultrasound of the lungs in predicting the risk of death and of the long-term pulmonary complications as consequences of Covid-19 pneumonia. The study will include repeated ultrasound investigations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive patients admitted to the University Hospital in Cracow (Poland) performed during hospitalization and after discharge. The relation of severity and the course of pneumonia revealed by ultrasound to clinical condition, long term complications, use of mechanical ventilation, admission to intensive care and results of laboratory tests will be examined.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity, Length of Hospitalization and Long-term Complications and of Covid-19 Infection
    Actual Study Start Date :
    Oct 10, 2020
    Actual Primary Completion Date :
    Mar 7, 2022
    Anticipated Study Completion Date :
    Aug 28, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Changes in the lungs on admission

    Patients with Covid-19 infection admitted to the University Hospital with changes in the ultrasound on admission, suggesting pneumonia.

    No changes in the lungs on admission

    Patients with Covid-19 infection admitted to the University Hospital without changes in the ultrasound on admission, suggesting pneumonia.

    Outcome Measures

    Primary Outcome Measures

    1. Relation of changes in ultrasound and progression to respiratory failure [Through study completion, an average of 1 year.]

      Comparison of percentage of patients with oxygenation index drop below 300 mmHg during 14 after inclusion between group with and without changes in the ultrasound on admission.

    2. Impact of ultrasonographic pneumonia signs on the day of admission on severity of COVID-19 infection [Through study completion, an average of 1 year.]

      Comparison of frequency of intensive care, ventilator use and of the number of days of hospital stay, between group with signs of pneumonia vs. group without signs of pneumonia in the ultrasound, on the day of admission.

    Secondary Outcome Measures

    1. Sensitivity of ultrasonographic pneumonia signs in detecting respiratory failure [Through study completion, an average of 1 year.]

      Correlation of the score reflecting severity of ultrasonographic pneumonia signs with oxygen saturation of arterial blood and with oxygen and carbon dioxide partial pressure in repetitive measurements.

    2. Sensitivity of ultrasound in detecting interstitial changes in the lungs [Through study completion, an average of 1 year.]

      Correlation of the score reflecting severity of ultrasonographic pneumonia signs with the volume of lung interstitium affected by pneumonia, measured in high resolution computer tomography scans.

    3. Impact change in severity of ultrasonographic pneumonia signs on severity of COVID-19 infection [Through study completion, an average of 1 year.]

      Comparison of frequency of intensive care, ventilator use and of the number of days of hospital stay, between group which improved and which did not improve in the score reflecting severity of ultrasonographic pneumonia signs from the measurement on the day of admission to measurement five days later.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients sufficiently medically ill to require hospital admission.

    • Confirmed SARS-CoV-2 infection by positive result on polymerase chain reaction testing of a nasopharyngeal sample not earlier than five days prior to inclusion.

    Exclusion Criteria:
    • Interstitial lung disease in the past.

    • Chronic respiratory insufficiency.

    • Significant bronchial obstruction n the day of admission to the University Hospital.

    • Pulmonary embolism during three months before admission.

    • Significant thorax deformity, which may disturb the investigation of the lungs with ultrasound.

    • Hemodynamic instability

    • Pregnancy (relative contraindication for computer tomography)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Jagiellonian University Medical College, Department of Neurology Kraków Poland 31503

    Sponsors and Collaborators

    • Jagiellonian University

    Investigators

    • Principal Investigator: Jakub M Antczak, MD, Jagiellonian University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Jakub Antczak, Principal Investigator, Jagiellonian University
    ClinicalTrials.gov Identifier:
    NCT04513210
    Other Study ID Numbers:
    • JagiellonianU67
    First Posted:
    Aug 14, 2020
    Last Update Posted:
    Mar 8, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 8, 2022